Grants

awarded

The METAvivor Research Program was established in 2009 with the specific goal of funding stage IV metastatic breast cancer research to one day, end death from metastatic breast cancer (MBC). The following list includes current and past grant recipients along with their progress reports.

FIONA YULL, PhD

Vanderbilt School of Medicine

Macrophage-based immunotherapy for eradication of pre-existing breast cancer metastases

Lin Zhang, PhD

The University of Texas MD Anderson Cancer Center

Presented in honor of Ashleigh Griffin

Altering the Metabolic Tumor Microenvironment to Impede Breast Cancer Brain Metastasis

Yun Zhao, PhD

University of Notre Dame

Presented by Metavivor Facebook Fundraisers

Targeting the pitfall of chemo-immunotherapy: Immunosuppressive myeloid cells induced by apoptosis

Guizhi Zhu, PhD

Virginia Commonwealth University

Presented by Southwest Florida Metsquerade in Memory of Amanda DeFiebre

Multi-epitope/di-adjuvant co-delivering albumin-binding vaccines (Medico-AlbiVax) for the combination immunotherapy of metastati